Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Bidirectional trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.
Fingolimod (Gilenya) eligibility extended by NHS England
Astrocyte CCL2 sustains immune cell infiltration in chronic experimental autoimmune encephalomyelitis.
Progressive Disorganization of Paranodal Junctions and Compact Myelin Due to Loss of DCC Expression by Oligodendrocytes.
Use of a Time-of-Flight Camera With an Omek Beckon™ Framework to Analyze, Evaluate and Correct in Real Time the Verticality of Multiple Sclerosis Patients during Exercise.
Neuromyelitis optica in children: a review of the literature.
The Effect of Fingolimod on Conversion of Acute Gadolinium-Enhancing Lesions to Chronic T1 Hypointensities in Multiple Sclerosis.
Excitotoxicity: Bridge to various triggers in neurodegenerative disorders.
Spinal cord tract diffusion tensor imaging reveals disability substrate in demyelinating disease.
Multiple sclerosis: Natalizumab reduces cortical pathology in relapsing-remitting multiple sclerosis.
The common marmoset as a novel animal model system for biomedical and neuroscience research applications.
Determinants of central nervous system adult neurogenesis are sex, hormones, mouse strain, age, and brain region.
Regulation of miRNA 219 and miRNA Clusters 338 and 17-92 in Oligodendrocytes.
Comparison of MERGE and Axial T2-Weighted Fast Spin-Echo Sequences for Detection of Multiple Sclerosis Lesions in the Cervical Spinal Cord.
Perceived changes and minimum clinically important difference of the Neurological Fatigue Index for multiple sclerosis (NFI-MS).
Primary varicella zoster infection associated with fingolimod treatment.
Protocol to isolate a large amount of functional oligodendrocyte precursor cells from the cerebral cortex of adult mice and humans.
[Multimodal complex treatment in multiple sclerosis : Influence on motor performance and need of care.]
Retinal nerve fibre layer thinning in patients with clinically isolated optic neuritis and early treatment with interferon-Beta.
Explaining temporal trends in annualised relapse rates in placebo groups of randomised controlled trials in relapsing multiple sclerosis: systematic review and meta-regression.
Expansion of CD27(high) plasmablasts in transverse myelitis patients that utilize VH4 and JH6 genes and undergo extensive somatic hypermutation.
Association between functional CD24 polymorphisms and susceptibility to autoimmune diseases: A meta-analysis.
The role of B cells in the onset of the first demyelinating event of optic neuritis.
Fingolimod effect on brain volume loss independently contributes to its effect on disability.
Impairment of endothelial function in patients with multiple sclerosis.
Pages
« first
‹ previous
…
253
254
255
256
257
258
259
260
261
…
next ›
last »